Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...

Malodorous, fungating wounds in the final stages of life for a patient with cancer have remained ... of tools available to control secondary infection and necrosis and promote healing in advanced ...

Abstract: Cytokine levels in skin wound fluid can provide valuable information on the progression of the local healing phases and help in making therapeutic decisions. The gold standard cytokine ...

The thickened skin will eventually go away, but the discoloration caused by psoriasis plaques may last up to a year. Discoloration is not permanent, and seeking treatment from a healthcare provider ...

But with promising early results from a phase 3 study in certain patients, the checkpoint inhibitor may have found its place. At a pre-specified interim analysis of Merck’s phase 3 Keynote-B96 ...

Department of Chemistry, School of Sciences and Engineering (SSE), The American University in Cairo (AUC), AUC Avenue, P.O. Box 74, New Cairo 11835, Egypt Department of Chemistry, School of Sciences ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...

SAN DIEGO — Disease-modifying antirheumatic drugs (DMARDs) and biologics were linked to as much as a 74.5% reduction in the risk for alopecia areata (AA) in patients with psoriasis, a new ...

Included are the evidence for GLP-1 Rs in the skin, as well as the drugs’ effects in wound healing, psoriasis, and HS. The authors also review the cutaneous side effects of GLP-1 RA medications.

The psoriasis patient group consisted of 32 females and 32 males, and the control group consisted of 28 females and 29 males. Disease types were classified as plaque, palmar, guttate ... vessels in ...